Financings in Brief: Digene
This article was originally published in The Gray Sheet
Executive Summary
Digene: Maker of DNA and RNA tests for disease detection files with SEC for a secondary offering of 2.5 mil. shares, including 2 mil. shares to be offered by the company and 500,000 by a selling shareholder. UBS Securities and Montgomery Securities are underwriters for the offering...
You may also be interested in...
Lack Of Industry Involvement In Scoping Process Exacerbates ‘Unworkable’ Timelines
Scientific advice could help companies make up for the lack of involvement in scoping, but slots are in short supply.
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.